If you suspect you have SIBO and your doctor orders a breath test, there's a decision you should understand: should the test use glucose or lactulose as the substrate? This isn't a trivial choice. The two substrates test different portions of the small intestine, have different sensitivity and specificity profiles, and can produce meaningfully different results in the same patient. Glucose breath testing has higher specificity (approximately 83%) but only detects overgrowth in the proximal small intestine. Lactulose breath testing covers the entire small intestine but has a higher false positive rate. Newer tests like trio-smart add hydrogen sulfide measurement to the mix. Understanding these differences empowers you to have an informed conversation with your gastroenterologist about which test — or combination of tests — gives you the best shot at an accurate diagnosis.
How SIBO Breath Testing Works: The Basics
All SIBO breath tests operate on the same fundamental principle: humans don't produce hydrogen (H2) or methane (CH4) gas — only bacteria and archaea do. When you ingest a sugar substrate on an empty stomach, it travels through your gastrointestinal tract. If excess bacteria are present in your small intestine, they ferment the substrate and produce measurable gases. These gases are absorbed through the intestinal wall into the bloodstream, transported to the lungs, and exhaled in your breath, where they can be measured by a breath analyzer.
The test measures gas production over time, plotting a curve of hydrogen and methane levels at 15-20 minute intervals for 2-3 hours. The diagnostic interpretation relies on the timing and magnitude of gas rises. An early rise (within 90 minutes) suggests fermentation is occurring in the small intestine, while later rises reflect normal colonic fermentation. The 2017 North American Consensus defines a positive result as a hydrogen rise of 20 ppm or more above baseline within 90 minutes, or a methane level of 10 ppm or more at any point during the test.
Glucose Breath Test: How It Works
The glucose breath test uses 75 grams of glucose (dextrose) dissolved in water as the test substrate. Glucose is a simple monosaccharide that is rapidly and completely absorbed in the proximal small intestine (duodenum and jejunum) — typically within the first 2-3 feet of the small bowel. In a healthy person, all the glucose is absorbed before it reaches the distal small intestine or colon, meaning bacteria in the colon never encounter it and no colonic gas is produced.
This absorption profile is both the glucose test's greatest strength and its primary limitation. Because glucose is absorbed so quickly, any gas produced during the test almost certainly comes from bacterial fermentation in the proximal small intestine — not from normal colonic bacteria. This gives the glucose test high specificity: when it's positive, you can be fairly confident that bacteria are present where they shouldn't be. Studies have documented glucose breath test specificity ranging from 78-83%, and sensitivity of approximately 20-65%.
ℹ️Specificity tells you how often a positive result is truly positive (few false positives). Sensitivity tells you how often the test catches real disease (few false negatives). An ideal test would have both above 90%. Neither SIBO breath test achieves that, which is why clinical context always matters.
Lactulose Breath Test: How It Works
The lactulose breath test uses 10 grams of lactulose dissolved in water. Lactulose is a synthetic disaccharide (made of galactose and fructose) that humans cannot digest or absorb. It passes through the entire small intestine intact and is only fermented by bacteria — either bacteria in the small intestine (if SIBO is present) or bacteria in the colon (which is normal). This means lactulose traverses the full length of the small bowel, giving it the ability to detect overgrowth anywhere along the small intestine, including the distal ileum.
The challenge with lactulose is interpretation. Because lactulose eventually reaches the colon (where it will always be fermented by normal colonic bacteria), every lactulose breath test produces a late rise in gas — that's expected. The diagnostic question is whether there's an early rise (before 90 minutes) that precedes the colonic rise, suggesting small intestinal fermentation. The classic positive pattern is a 'double peak': an early rise from SIBO bacteria in the small intestine, followed by a second rise from normal colonic fermentation. However, this double-peak pattern is not always clearly distinguishable, especially in patients with fast gut transit.
Lactulose breath test sensitivity for SIBO has been reported at 31-68%, while specificity ranges from 44-85%. The wide ranges reflect differences in study populations, preparation protocols, and interpretation criteria. The lower specificity compared to glucose means more false positives — some positive lactulose tests may be detecting rapid transit rather than true small intestinal overgrowth.
Head-to-Head Comparison: Glucose vs Lactulose
| Feature | Glucose Breath Test | Lactulose Breath Test |
|---|---|---|
| Substrate dose | 75g glucose in water | 10g lactulose in water |
| Absorption | Rapidly absorbed in proximal small intestine | Not absorbed — traverses entire GI tract |
| Area tested | Proximal small intestine only (duodenum/jejunum) | Entire small intestine including distal ileum |
| Sensitivity | 20-65% | 31-68% |
| Specificity | 78-83% | 44-85% |
| False positives | Low — gas almost certainly from small intestine | Higher — rapid transit can mimic SIBO |
| False negatives | Higher — misses distal SIBO entirely | Moderate — interpretation ambiguity |
| Test duration | 2 hours | 2-3 hours |
| Patient comfort | Sweet taste, generally well-tolerated | Sweet taste, may cause gas/cramping/diarrhea |
| Diabetic considerations | 75g glucose load — significant for diabetics | No glycemic impact — safe for diabetics |
| Gold standard comparison | Better validated against jejunal aspirate culture | Less validated; no perfect reference standard |
The Case for Glucose: When Specificity Matters More
Glucose testing is generally preferred when your clinician wants to minimize false positives — that is, when the priority is being confident that a positive result represents true SIBO rather than a testing artifact. This is particularly important if a positive test will lead to antibiotic treatment, because you don't want to take a course of rifaximin based on a false positive caused by rapid colonic transit.
The glucose test's 83% specificity means that approximately 17% of positive results may be false positives — a meaningful but manageable rate. Its main weakness is that it can only detect overgrowth in the proximal small intestine. If your SIBO is primarily in the ileum (the last section of the small intestine, near the ileocecal valve), a glucose test will likely miss it entirely because all the glucose is absorbed before reaching that area. Research published in Neurogastroenterology & Motility in 2014 estimated that glucose testing misses approximately 35-40% of SIBO cases localized to the distal small bowel.
The Case for Lactulose: When Coverage Matters More
Lactulose is preferred when your clinician wants to screen the entire small intestine, including the distal ileum where SIBO is common, particularly in patients with ileocecal valve dysfunction, prior abdominal surgeries, or Crohn's disease affecting the terminal ileum. Because lactulose isn't absorbed, it physically traverses every inch of the small bowel, giving bacteria anywhere along its length an opportunity to ferment it.
The tradeoff is interpretation complexity. The lactulose test requires distinguishing between an early small intestinal peak and the expected later colonic peak. In patients with fast transit times — which includes many IBS-D patients who are being tested for SIBO — the substrate may reach the colon within 60-70 minutes rather than the assumed 90+ minutes. This colonic arrival can be misinterpreted as small intestinal fermentation, producing a false positive. A 2015 study in Digestive Diseases and Sciences found that oro-cecal transit time varied from 40 to 160 minutes across healthy subjects, making the 90-minute cutoff somewhat arbitrary.
ℹ️Many experienced SIBO practitioners prefer lactulose over glucose because distal SIBO is clinically common and glucose testing systematically misses it. However, they interpret lactulose results conservatively — requiring a clear early peak with a distinct nadir before the colonic peak, rather than any borderline rise.
Trio-Smart: Adding Hydrogen Sulfide to the Equation
The trio-smart breath test, developed by Dr. Mark Pimentel's group at Cedars-Sinai and offered through Gemelli Biotech, represents the most significant advancement in SIBO breath testing in recent years. It measures three gases — hydrogen, methane, and hydrogen sulfide — using a single lactulose substrate test. Conventional breath tests only measure hydrogen and methane, which means they systematically miss hydrogen sulfide-dominant SIBO (sometimes called SIBO Type 3).
Hydrogen sulfide-producing bacteria (primarily Fusobacterium and Desulfovibrio species) consume hydrogen rather than producing it, which can actually lower hydrogen readings and mask their presence on conventional tests. These organisms produce hydrogen sulfide gas, which is associated with diarrhea-predominant symptoms, sulfur-smelling gas, and has been linked to inflammatory processes in the gut lining. A positive hydrogen sulfide result on trio-smart is defined as 3 ppm or more at any point during the test.
Dr. Pimentel's research, published in Clinical and Translational Gastroenterology in 2020, found that approximately 30-35% of patients with IBS-like symptoms who tested negative on conventional hydrogen/methane breath testing had elevated hydrogen sulfide levels. This suggests that a significant portion of SIBO cases have been systematically missed by older two-gas tests. The trio-smart test uses the lactulose substrate, so it covers the entire small intestine while measuring all three clinically relevant gases.
Which Test Should You Ask For?
The best test for you depends on your clinical situation, your symptoms, and what's available through your provider. Here are practical recommendations based on common scenarios.
Test Selection Guide
- If this is your first SIBO test and you want comprehensive screening: Request the trio-smart test (lactulose, three gases). It covers the entire small intestine and measures all three gas types, giving the broadest diagnostic coverage available. This is the most informative single test.
- If you have diabetes or insulin resistance: The glucose test delivers 75 grams of glucose, which is equivalent to a standard oral glucose tolerance test and will significantly spike blood sugar. Lactulose has no glycemic impact. Choose lactulose if blood sugar management is a concern.
- If you tested negative on lactulose but symptoms persist: Consider a glucose test to confirm the negative result. If glucose is also negative, consider trio-smart if your prior test only measured two gases, or discuss empiric treatment with your clinician.
- If you tested negative on glucose but symptoms persist: This is a clear indication for lactulose or trio-smart testing, as glucose systematically misses distal SIBO. Up to 40% of SIBO may be in the distal small intestine where glucose cannot reach.
- If your practitioner suspects methane-dominant SIBO (IMO): Any test measuring methane will work, as methane is detectable regardless of substrate. However, lactulose may be preferred because methanogens are often more prevalent in the distal small intestine.
- If you have predominantly diarrhea with sulfur-smelling gas: Strongly consider trio-smart, as hydrogen sulfide-dominant SIBO is specifically associated with diarrhea and will be missed by conventional two-gas tests.
- If your insurance only covers one option: Take whatever is covered. An imperfect test is better than no test. Both substrates can diagnose SIBO, and a skilled clinician will interpret results in the context of your symptoms.
Limitations of Both Tests — and What the Future Holds
It's important to be honest about the limitations of breath testing in general. Neither substrate achieves sensitivity or specificity above 85%, and the gold standard comparison (jejunal aspirate culture) is itself imperfect. Culture requires an endoscopy, only samples one location in the small intestine, misses anaerobic organisms, and uses a threshold (10^3 CFU/mL) that some researchers argue is too low. There is no perfect SIBO test.
Emerging technologies may improve diagnostic accuracy in the future. Dr. Pimentel's group is investigating blood-based biomarkers (anti-CdtB and anti-vinculin antibodies) that reflect post-infectious IBS/SIBO mechanisms rather than measuring bacterial gas directly. These are already available through IBS-Smart testing and may be used alongside breath testing for a more comprehensive diagnostic picture. Additionally, capsule-based technologies that sample intestinal contents directly (such as the InvivoBiotech SmartPill and research-stage bacterial sensor capsules) may eventually offer real-time, location-specific data about bacterial populations throughout the small intestine.
Track Your Testing Journey with GLP1Gut
Whether you choose glucose, lactulose, or trio-smart, tracking your test results alongside your daily symptoms gives you and your practitioner the full diagnostic picture. The GLP1Gut app lets you log breath test results, record your symptoms before and after testing, set preparation reminders (when to stop medications, when to start the prep diet, when to begin fasting), and compare results across multiple tests if you need to retest after treatment. Many patients test 2-3 times during their SIBO journey — having all results and symptom data in one timeline makes it easy to see whether treatment is working.
ℹ️Medical disclaimer: This article is for informational purposes only and does not constitute medical advice. Discuss test selection with your gastroenterologist, who can recommend the most appropriate test based on your specific clinical situation, symptom pattern, and medical history.